We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Neutrophil-Lymphocyte Ratio Proves Possible Biomarker for ED

By LabMedica International staff writers
Posted on 30 May 2019
Erectile dysfunction is described as the impotency to obtain or sustain an erection sufficiently in order to enable convincing sexual intercourse. More...
Erectile dysfunction (ED) is estimated to affect about 75% of men over the age of 75 and 20% of men over the age of 20.

The association among many diseases, inflammatory markers and also their roles in the disease etiopathogenesis are important. The literature reveals that emerge and severity of ED are related with markers and mediators of inflammation and endothelial dysfunction.

Urologists at the Ordu University (Ordu, Turkey) and their colleagues evaluated 90 patients with erectile dysfunction (ED) and 94 healthy subjects from their internal medicine and urology clinics. As diagnosis criteria, they used the first five questions of International Index for Erectile Function. The duration of erectile dysfunction was asked and recorded. Height, weight and waist circumference of patients were measured.

The team performed total blood count, sedimentation, C-reactive protein, blood urea nitrogen (BUN), creatine, cholesterol, Low-density lipoprotein cholesterol (LDL-C) and High-density lipoprotein cholesterol (HDL-C) measurements of the patients were recorded. The neutrophil-lymphocyte ratio (NLR) was computed as the total neutrophil count separated by the total lymphocyte count.

The investigators found that there were statistically significant differences in terms of NLR between the control 1.038 (range: 0.507-1.92) and ED 2.38 (1.67.0-3.00) groups. According to the multivariate logistic regression analysis, duration of ED (Cut off: 7.5 month) predicted ED with 78.8% sensitivity and 63.1% specificity (AUC: < 0.001). Moreover, NLR (Cut off: 1.574) predicted ED with 81.8% sensitivity and 67.0% specificity (AUC: < 0.001) according to the multivariate logistic regression analysis.

The authors concluded that that the neutrophil-lymphocyte ratio was higher in patient group than the control group, and that the neutrophil-lymphocyte ratio (NLR) predicted ED and it might be helpful in diagnosing erectile dysfunction. The study was published on May 5, 2019, in the Urology Journal.

Related Links:
Ordu University


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Prefilled Tubes
Prefilled 5.0ml Tubes
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.